Companies House 16085600 2025-11-30 2025-11-30 2024-11-18 false iso4217:GBP xbrli:pure 16085600 2025-11-30 16085600 2024-11-18 2025-11-30 16085600 curr:PoundSterling 2024-11-18 2025-11-30 16085600 uk-bus:PrivateLimitedCompanyLtd 2024-11-18 2025-11-30 16085600 uk-bus:FRS102 2024-11-18 2025-11-30 16085600 uk-bus:AuditExempt-NoAccountantsReport 2024-11-18 2025-11-30 16085600 uk-bus:FullAccounts 2024-11-18 2025-11-30 16085600 uk-bus:RegisteredOffice 2024-11-18 2025-11-30 16085600 uk-bus:Director1 2024-11-18 2025-11-30 16085600 uk-bus:Director2 2024-11-18 2025-11-30 16085600 uk-bus:Director3 2024-11-18 2025-11-30 16085600 uk-bus:Director4 2024-11-18 2025-11-30 16085600 uk-bus:Director5 2024-11-18 2025-11-30 16085600 uk-bus:Director6 2024-11-18 2025-11-30 16085600 uk-bus:Director7 2024-11-18 2025-11-30 16085600 uk-bus:Director8 2024-11-18 2025-11-30 16085600 uk-bus:Director9 2024-11-18 2025-11-30 16085600 uk-bus:Director10 2024-11-18 2025-11-30 16085600 uk-bus:Director11 2024-11-18 2025-11-30 16085600 uk-bus:Director12 2024-11-18 2025-11-30 16085600 uk-bus:Director13 2024-11-18 2025-11-30 16085600 uk-bus:Director14 2024-11-18 2025-11-30 16085600 uk-bus:Director15 2024-11-18 2025-11-30 16085600 uk-bus:Director16 2024-11-18 2025-11-30 16085600 uk-bus:Director17 2024-11-18 2025-11-30 16085600 uk-bus:Director18 2024-11-18 2025-11-30 16085600 uk-bus:Director19 2024-11-18 2025-11-30 16085600 uk-bus:Director20 2024-11-18 2025-11-30 16085600 uk-bus:Director21 2024-11-18 2025-11-30 16085600 uk-bus:CompanySecretary1 2024-11-18 2025-11-30 16085600 core:AfterOneYear 2025-11-30 16085600 core:WithinOneYear 2025-11-30 16085600 core:WithinOneYear 2024-11-18 2025-11-30 16085600 core:AfterOneYear 2025-11-30 16085600 core:AfterOneYear 2024-11-18 2025-11-30 16085600 core:ShareCapital 2025-11-30 16085600 core:SharePremium 2025-11-30 16085600 core:OtherReservesSubtotal 2025-11-30 16085600 core:RevaluationReserve 2025-11-30 16085600 core:RetainedEarningsAccumulatedLosses 2025-11-30 16085600 1 2024-11-18 2025-11-30 16085600 2 2024-11-18 2025-11-30 16085600 3 2024-11-18 2025-11-30 16085600 core:LandBuildings 2024-11-18 2025-11-30 16085600 core:LandBuildings 2025-11-30 16085600 core:PlantMachinery 2024-11-18 2025-11-30 16085600 core:PlantMachinery 2025-11-30 16085600 core:FurnitureFittingsToolsEquipment 2024-11-18 2025-11-30 16085600 core:FurnitureFittingsToolsEquipment 2025-11-30 16085600 core:OfficeEquipment 2024-11-18 2025-11-30 16085600 core:OfficeEquipment 2025-11-30 16085600 core:Vehicles 2024-11-18 2025-11-30 16085600 core:Vehicles 2025-11-30 16085600 core:NetGoodwill 2024-11-18 2025-11-30 16085600 core:NetGoodwill 2025-11-30 16085600 core:IntangibleAssetsOtherThanGoodwill 2024-11-18 2025-11-30 16085600 core:IntangibleAssetsOtherThanGoodwill 2025-11-30

# SMIR MEDICAL LIMITED

## Company Registration Number:
16085600 (England and Wales)

## Unaudited statutory accounts for the year ended 30 November 2025

## Period of accounts

## Start date: 18 November 2024

## End date: 30 November 2025

# SMIR MEDICAL LIMITED

## Contents of the Financial Statements

for the Period Ended 30 November 2025

Balance sheet |
Additional notes |
Balance sheet notes |

# SMIR MEDICAL LIMITED

## Balance sheet

As at 30 November 2025

| Notes | 2025
--- | --- | ---
|  | £
Current assets
Cash at bank and in hand: |  | 5,567 |
Total current assets: |  | 5,567
Creditors: amounts falling due within one year: | 3 | ( 1,058 ) |
Net current assets (liabilities): |  | 4,509
Total assets less current liabilities: |  | 4,509
Total net assets (liabilities): |  | 4,509
Capital and reserves
Called up share capital: |  | 1 |
Profit and loss account: |  | 4,508 |
Total Shareholders' funds: |  | 4,509

The notes form part of these financial statements

# SMIR MEDICAL LIMITED

## Balance sheet statements

For the year ending 30 November 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 20 April 2026
and signed on behalf of the board by:

Name: Saad Hassan Mir
Status: Director

The notes form part of these financial statements

# SMIR MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 30 November 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

  Turnover policy

  The Turnover is the revenue received from clients during the accounting period excluded VAT.

# SMIR MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 30 November 2025

- ## 2. Employees

  | 2025
  --- | ---
  Average number of employees during the period | 1 |

# SMIR MEDICAL LIMITED

## Notes to the Financial Statements

for the Period Ended 30 November 2025

## 3. Creditors: amounts falling due within one year note

| 2025
--- | ---
| £
Taxation and social security | 1,058 |
Total | 1,058